Clinical data management for research teams
As a portal solution, TrialComplete LatePhase gives a consistent, intuitive base for managing clinical-trial data—optimised for multi-site research and pharma trials.
Successful Data Capture for Clinical Trials
Efficient, scalable management of multi-site, image-rich clinical-trial data—discover what TrialComplete LatePhase offers research and industry.
TrialComplete LatePhase is a web-based data-management system that simplifies capture, processing and archiving of clinical-trial data for research teams in universities, hospitals and the pharmaceutical industry. Beyond consistent multi-site management, it enables seamless handling of clinical imaging in DICOM format: images are uploaded at the trial site and linked directly to the visit context.
Profile-based, automated pseudonymisation ensures that privacy rules are met; only pseudonymised images leave the hospital network via a secure connection and are stored on the TrialComplete server. All subsequent steps stay within the trial context, so the provenance of measurement data remains traceable. TrialComplete therefore supports secure, end-to-end data handling—from capture through long-term archiving.
Built on CDISC ODM/SDM, the platform integrates smoothly into existing environments and scales to any trial size, giving teams flexible, cost-efficient late-phase clinical-data management and full control of their data.
Late-phase research produces large, heterogeneous datasets. TrialComplete LatePhase delivers a secure, efficient solution tailored to this challenge: it streamlines capture, management and archiving of trial data and DICOM images. Automated pseudonymisation and links to local PACS and external services provide maximum data security, while extensive interfaces prevent media breaks and cut admin effort. High interoperability eases integration with current systems and protects complex data right through to long-term storage.
The result: flexibility and safety for trials of any scale.
TrialComplete LatePhase targets research teams in universities, hospitals and pharma who need a scalable, secure, end-to-end solution for managing and archiving clinical-trial data. Late-phase (IIb / III) and academic, multi-site, image-heavy trials benefit most. Teams that process large data volumes and require tight integration with external systems while maintaining top-tier security will find TrialComplete LatePhase ideal.
Functions of
TrialComplete Latephase
Trial data are processed strictly under participant pseudonyms. An optional external pseudonymisation service guarantees a seamless, reliable workflow.
DICOM images are pseudonymised just as easily: configurable profiles strip or replace DICOM tags before transfer, preserving privacy without slowing the trial.
Within TrialComplete, imaging data can be assigned to the correct participant visit directly at the trial site and uploaded with full traceability. During the upload the platform automatically pseudonymises the DICOM header in line with the predefined pseudonymisation profile, ensuring that no identifying tags ever leave the hospital network. All subsequent processing steps are performed inside the same study context, preserving an unbroken audit trail from raw image to final data point.
For image analysis the Fraunhofer MEVIS Satori viewer is seamlessly embedded in TrialComplete. Investigators can open the image, take measurements, annotate regions of interest and have the numerical results transferred instantly—and without transcription errors—into the corresponding fields of the electronic visit form. The entire workflow, from first upload through measurement and documentation, is therefore covered end-to-end without media breaks, duplicate data entry or manual reconciliation.
Where preferred, data capture can also be handled through structured import and export: image sets can be transferred to external systems, and XML result files can be re-imported into TrialComplete. This option eliminates tedious manual re-keying while still maintaining full data integrity and traceability.
TrialComplete offers a rich interface layer that lets you embed the platform effortlessly in any existing technology ecosystem. Research teams can choose from multiple connection options, including:
- bidirectional data exchange with other EDC platforms for hybrid or legacy scenarios,
- seamless linkage to external pseudonymisation services—optionally with token-based hand-offs that permit additional systems (e.g. biobanks or analytics hubs) to work on the same data set under a shared pseudonym,
- structured download of imaging data for third-party DICOM viewers plus automated ingestion of the associated, standards-compliant result files, and
- a dedicated REST API for secondary-use management. The API lets authorised users select specific images, route them through an approval workflow and, once cleared, deliver re-pseudonymised copies to downstream research projects.
Because every interface follows open standards such as CDISC ODM/SDM and HL7 FHIR, integration work is minimal, and long-term maintainability is guaranteed. These flexible connectivity options safeguard an efficient clinical-trial data-management process while protecting your investment in established IT landscapes.
Our services – your benefits
TrialComplete LatePhase can streamline your late-phase trial processes.
Take a look at the benefits:
A flexible solution for any trial size with transparent costs. Capture and archive Phase IIb/III and academic data securely across multi-site, image-based trials, adapting to diverse research needs.
Hosted in EU-based, ISO/IEC 27001-certified Telekom data centres, with robust pseudonymisation and end-to-end protection for DICOM images and all trial data.
Manage trials of any size with full data control and seamless workflows—from capture to archiving—at a cost-efficient price point.
Manage trials of any size with full data control and seamless workflows—from capture to archiving—at a cost-efficient price point.
How secure are the data in TrialComplete LatePhase?
TrialComplete LatePhase stores data in Telekom-owned, ISO/IEC 27001-certified EU data centres and guarantees strong pseudonymisation. Telekom’s own Privacy & Security Assessment underpins the high data-protection standards of this SaaS.
Can the system be integrated into existing infrastructures?
Yes. Numerous interfaces support integration with external CDMS and imaging systems. Trial data can be sent to external platforms, and re-pseudonymised images can be released for secondary use via an approval workflow.
Is TrialComplete LatePhase suited to international trials?
Absolutely. The platform scales for multi-site, international trials and adapts flexibly to varied requirements.
What is the difference between TrialComplete EarlyPhase and TrialComplete LatePhase?
TrialComplete EarlyPhase is specifically designed for early clinical trials (Phase I/IIa) and supports process control (automation) and subject management. The LatePhase Edition, on the other hand, is aimed at multisite, scientific / academic trials that process large medical image data sets. While the EarlyPhase Edition focuses on the rapid execution of EP studies and the integration of laboratory data, the LatePhase Edition enables seamless processing of image data in DICOM format.
What is the difference between TrialComplete and TrialSite?
TrialComplete focuses on the management and organization of the entire clinical trial and accompanies the process from planning to evaluation of the trial data (clinical trial management). TrialSite, on the other hand, focuses on the management of the clinical trial sites themselves and optimizes administrative processes such as cost calculation and billing (clinical site management).